Venture Outlook 2020

Venture Outlook 2020

Venture Outlook 2020
Join us to discuss the venture landscape in 2020 and review San Diego, SoCal, and national data.

Presentations from CEO and President of the National Venture Capital Association, Bobby Franklin, and local data source and expert with Correlation Ventures, David Coats.

Learn about the current venture landscape from two different expert viewpoints.

National Venture Capital Association Correlation Ventures

Hourly Schedule

Venture Outlook 2020

4:30pm - 5:30pm
Networking
Refreshments provided
5:30pm - 6:30pm
Program
Presentation of past trends and projections from CEO and President of the National Venture Capital Association, Bobby Franklin, and local data source and expert with Correlation Ventures, David Coats
Speakers:
Bobby Franklin, David Coats
Bobby Franklin
Bobby Franklin
President & CEO, National Venture Capital Association
Bobby Franklin is the President & CEO of the National Venture Capital Association (NVCA) whose membership includes hundreds of venture capital firms and thousands of individuals that invest in the entrepreneurial ecosystem. With over 25 years of experience in advocacy and public policy in our nation’s capital, Bobby took the helm of NVCA in September of 2013 after nearly a decade at CTIA – The Wireless Association, where he first served as head lobbyist and then spent the next eight years as the association’s Executive Vice President. Prior to joining CTIA, Bobby worked for wireless provider Alltel Corporation as both their lobbyist and then head of the company’s Washington office. An Arkansas native, Bobby got his start in Washington working in the U.S. Senate for Senator David Pryor of Arkansas.
David Coats
David Coats
Partner, Correlation Ventures
As a founder and Managing Director of Correlation Ventures, David helps lead the firm. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital. David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering.

Date

Feb 11 2020

Time

4:30 pm - 6:30 pm

More Info

Register
JLabs

Location

JLabs
3210 Merryfield Row, San Diego, CA 92121
Category
Register

Speakers

  • Bobby Franklin
    Bobby Franklin
    President & CEO, National Venture Capital Association

    Bobby Franklin is the President & CEO of the National Venture Capital Association (NVCA) whose membership includes hundreds of venture capital firms and thousands of individuals that invest in the entrepreneurial ecosystem. With over 25 years of experience in advocacy and public policy in our nation’s capital, Bobby took the helm of NVCA in September of 2013 after nearly a decade at CTIA – The Wireless Association, where he first served as head lobbyist and then spent the next eight years as the association’s Executive Vice President.
    Prior to joining CTIA, Bobby worked for wireless provider Alltel Corporation as both their lobbyist and then head of the company’s Washington office. An Arkansas native, Bobby got his start in Washington working in the U.S. Senate for Senator David Pryor of Arkansas.

  • David Coats
    David Coats
    Partner, Correlation Ventures

    As a founder and Managing Director of Correlation Ventures, David helps lead the firm. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital. David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering.

QR Code